116 related articles for article (PubMed ID: 37528722)
1. Determination of PDK1, SLC2A1, EGFR, PTEN, CD276 Gene Expression Levels and IDH1 Gene R132H Polymorphism in Brain Tumor Tissues.
Korkmaz S; Soylemez E; Soylemez Z; Solak M
Turk Neurosurg; 2023; 33(6):1086-1092. PubMed ID: 37528722
[TBL] [Abstract][Full Text] [Related]
2. Relationship between PTEN gene expression and differentiation of human glioma.
Yang Y; Shao N; Luo G; Li L; Nilsson-Ehle P; Xu N
Scand J Clin Lab Invest; 2006; 66(6):469-75. PubMed ID: 17000554
[TBL] [Abstract][Full Text] [Related]
3. Coexisting lipomatous meningioma and glioblastoma in Cowden syndrome: A unique tumor association.
Prieto R; Hofecker V; Corbacho C
Neuropathology; 2023 Feb; 43(1):110-116. PubMed ID: 36003032
[TBL] [Abstract][Full Text] [Related]
4. Gene expression analysis of an EGFR indirectly related pathway identified PTEN and MMP9 as reliable diagnostic markers for human glial tumor specimens.
Comincini S; Paolillo M; Barbieri G; Palumbo S; Sbalchiero E; Azzalin A; Russo MA; Schinelli S
J Biomed Biotechnol; 2009; 2009():924565. PubMed ID: 19657395
[TBL] [Abstract][Full Text] [Related]
5. Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.
Yadav AK; Renfrow JJ; Scholtens DM; Xie H; Duran GE; Bredel C; Vogel H; Chandler JP; Chakravarti A; Robe PA; Das S; Scheck AC; Kessler JA; Soares MB; Sikic BI; Harsh GR; Bredel M
JAMA; 2009 Jul; 302(3):276-89. PubMed ID: 19602687
[TBL] [Abstract][Full Text] [Related]
6. mRNA expression of programmed cell death ligand 1 and components of the phosphatidylinositol 3-kinase/AKT/phosphatase and tensin homolog pathway in epidermal growth factor receptor mutation-positive lung adenocarcinoma.
Han K; Zhang Y
J Cancer Res Ther; 2019; 15(4):914-920. PubMed ID: 31436252
[TBL] [Abstract][Full Text] [Related]
7. Prognosis in human glioblastoma based on expression of ligand growth hormone-releasing hormone, pituitary-type growth hormone-releasing hormone receptor, its splicing variant receptors, EGF receptor and PTEN genes.
Mezey G; Treszl A; Schally AV; Block NL; Vízkeleti L; Juhász A; Klekner A; Nagy J; Balázs M; Halmos G; Bognár L
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1641-9. PubMed ID: 24878932
[TBL] [Abstract][Full Text] [Related]
8. Exploring the role of epidermal growth factor receptor variant III in meningeal tumors.
Rana R; Rathi V; Chauhan K; Jain K; Chhabra SS; Acharya R; Kalra SK; Gupta A; Jain S; Ganguly NK; Yadav DK
PLoS One; 2021; 16(9):e0255133. PubMed ID: 34582442
[TBL] [Abstract][Full Text] [Related]
9. Molecular classification of glioblastoma based on immunohistochemical expression of EGFR, PDGFRA, NF1, IDH1, p53 and PTEN proteins.
Jankowska S; Lewandowska M; Masztalewicz M; Sagan L; Nowacki P; Urasińska E
Pol J Pathol; 2021; 72(1):1-10. PubMed ID: 34060283
[TBL] [Abstract][Full Text] [Related]
10. C-terminally truncated form of αB-crystallin is associated with IDH1 R132H mutation in anaplastic astrocytoma.
Avliyakulov NK; Rajavel KS; Le KM; Guo L; Mirsadraei L; Yong WH; Liau LM; Li S; Lai A; Nghiemphu PL; Cloughesy TF; Linetsky M; Haykinson MJ; Pope WB
J Neurooncol; 2014 Mar; 117(1):53-65. PubMed ID: 24473683
[TBL] [Abstract][Full Text] [Related]
11. An analysis of the prognostic value of IDH1 (isocitrate dehydrogenase 1) mutation in Polish glioma patients.
Lewandowska MA; Furtak J; Szylberg T; Roszkowski K; Windorbska W; Rytlewska J; Jóźwicki W
Mol Diagn Ther; 2014 Feb; 18(1):45-53. PubMed ID: 23934769
[TBL] [Abstract][Full Text] [Related]
12. Expression and gene doses changes of the p53-regulator PPM1D in meningiomas: a role in meningioma progression?
Fukami S; Riemenschneider MJ; Kohno M; Steiger HJ
Brain Tumor Pathol; 2016 Jul; 33(3):191-9. PubMed ID: 26942600
[TBL] [Abstract][Full Text] [Related]
13. Expression of cyclin D2, P53, Rb and ATM cell cycle genes in brain tumors.
Kheirollahi M; Mehr-Azin M; Kamalian N; Mehdipour P
Med Oncol; 2011 Mar; 28(1):7-14. PubMed ID: 20077038
[TBL] [Abstract][Full Text] [Related]
14. IDH1 and IDH2 mutations, immunohistochemistry and associations in a series of brain tumors.
Mellai M; Piazzi A; Caldera V; Monzeglio O; Cassoni P; Valente G; Schiffer D
J Neurooncol; 2011 Nov; 105(2):345-57. PubMed ID: 21643842
[TBL] [Abstract][Full Text] [Related]
15. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
[TBL] [Abstract][Full Text] [Related]
16. Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma.
Raghunathan A; Olar A; Vogel H; Parker JR; Coventry SC; Debski R; Albarracin CT; Aldape KD; Cahill DP; Powell SZ; Fuller GN
Ann Diagn Pathol; 2012 Aug; 16(4):255-9. PubMed ID: 22445362
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity.
Rong Y; Belozerov VE; Tucker-Burden C; Chen G; Durden DL; Olson JJ; Van Meir EG; Mackman N; Brat DJ
Cancer Res; 2009 Mar; 69(6):2540-9. PubMed ID: 19276385
[TBL] [Abstract][Full Text] [Related]
18. Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors.
Boado RJ; Black KL; Pardridge WM
Brain Res Mol Brain Res; 1994 Nov; 27(1):51-7. PubMed ID: 7877454
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome analysis reveals distinct gene expression profiles in astrocytoma grades II-IV.
Narsia N; Ramagiri P; Ehrmann J; Kolar Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):261-271. PubMed ID: 28452381
[TBL] [Abstract][Full Text] [Related]
20. Utility of EGFR and PTEN numerical aberrations in the evaluation of diffusely infiltrating astrocytomas. Laboratory investigation.
Mott RT; Turner KC; Bigner DD; McLendon RE
J Neurosurg; 2008 Feb; 108(2):330-5. PubMed ID: 18240930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
